Comparing Dupilumab vs Omalizumab
| Dupilumab | Omalizumab |
|
|---|
| Dupilumab | Omalizumab |
|
|---|---|---|
|
Prescription only
Prescribed for Eosinophilic Esophagitis, Chronic Rhinosinusitis With Nasal Polyps, Prurigo Nodularis, Eczema, Asthma - Maintenance, Atopic Dermatitis, Asthma, Bullous Pemphigoid, COPD, Urticaria... View more |
Prescription only
Prescribed for Urticaria, Food Allergies, Asthma - Maintenance, Chronic Rhinosinusitis With Nasal Polyps, Nasal Polyps, Asthma. Omalizumab may also be used for purposes not listed in this medication guide. View more |
Related suggestions Asthma, Maintenance
Urticaria
Chronic Rhinosinusitis With Nasal Polyps
Popular comparisons
|
| More about Dupilumab | More about Omalizumab | |
| Ratings & Reviews | ||
|
Dupilumab has an average rating of 7.3 out of 10 from a total of 545 ratings on Drugs.com. 61% of reviewers reported a positive effect, while 19% reported a negative effect. |
Omalizumab has an average rating of 7.6 out of 10 from a total of 268 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 18% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Dupilumab side effects |
View all Omalizumab side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Dupixent | Omlyclo, Xolair | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
N/A |
624 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 98 drugs are known to interact with Dupilumab:
|
A total of 32 drugs are known to interact with Omalizumab:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
| Disease Interactions | ||
| First Approval Date | ||
|
N/A |
N/A |
|
| WADA Class View classifications | ||
|
N/A |
N/A |
|
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.